FdaApplication

ANDA 207421

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASCENT PHARMACEUTICALS INC
application_typeANDA
approval_date2020-02-07

Products (3)

ProductActive ingredientStrengthDosage form
DRONABINOLDRONABINOL2.5MGCAPSULE;ORAL
DRONABINOLDRONABINOL10MGCAPSULE;ORAL
DRONABINOLDRONABINOL5MGCAPSULE;ORAL

3 products